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Abstract The HIV nucleocapsid (NC) protein contains, as those 
of other retroviruses, two Cys-His arrays which function as zinc 
finger binding domains. The nucleic acid binding properties of 
retroviral NC have been previously demonstrated. In this study, 
we characterized the DNA binding ability of the zinc-bound and 
zinc-free forms of HIV NC. We found that in addition to binding 
single-stranded DNA, both forms bind and unwind supercoiled 
plasmid DNA. The binding ability of the zinc-bound form was 
higher than the zinc-free form. In addition we showed the forma- 
tion of NC protein-DNA cleavable complex which is the result 
of a presumably covalent bond formed between the protein and 
the phosphate moiety of the DNA backbone. The NC unwinding 
activity and the protein-DNA cleavable complex formation re- 
sembles the first step of the relaxing mechanism of DNA topoi- 
somerase. Our results shed light on the possibility of a novel 
physiological function for the HIV NC protein in the viral life 
cycle. 
Key words. HIV nucleocapsid protein; Supercoiled DNA; 
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I. Introduction 
Human immunodeficiency virus type 1 (HIV-I) is the etiol- 
ogical agent of acquired immune deficiency syndrome (AIDS) 
[1 3]. Its replication is controlled by a complex system of viral 
and cellular egulatory proteins, some of which act at the tran- 
scriptional and others at the post transcriptional level [4]. 
Retroviruses establish persistent infection by integrating provi- 
ral DNA into the host cell genome [5]. It is possible that both 
provirus integration and expression require topological 
changes [6]. DNA topoisomerases are essential nuclear en- 
zymes which control and modify the topological state of DNA. 
We have demonstrated a topoisomerase I (topo I) activity in 
purified virions of HIV-I, equine infectious anemia virus 
(EIAV) [7], Moloney murine leukemia virus [8] and human T 
cell leukemia virus (unpublished data). We have recently puri- 
fied the topo I activity from EIAV particles and found that this 
*Corresponding author. Fax: (972) (7) 277453. 
activity is associated with the pl 1 nucleocapsid protein (manu- 
script in preparation). 
As in other replication competent retroviruses, the HIV 
genome contains the structural genes gag, pol and env as well 
as protease and regulatory genes. The gag gene encodes a 55 
kDa core precursor polypeptide, pr55 g".~ which is cleaved by the 
viral protease to the matrix antigen, the capsid antigen, the 
nucleocapsid (NC) and three other proteins designed p l, p2 and 
p6 [9]. The NC is a 7 kDa protein (p7) containing two stretches 
of Cys-X2-Cys-X4-His-Xa-Cys which are known as Cysteine- 
Histidine arrays [9]. Such arrays are also present in the NC of 
most other retroviruses and are presumably involved in the 
viral RNA packaging by pr55 g"e during virus assembly [10 15]. 
They are also required for the subsequent functions of NC 
within the mature virions, such as the dimerization of the 
genomic viral RNA [16] and the binding of the primer tRNA 
to the primer binding sequence in this genomic RNA [17]. 
Nucleocapsid proteins from several retroviruses bind single- 
stranded DNA and RNA [18 20] and are capable of unwinding 
folded RNA structures by binding selectively to single-stranded 
RNA [21]. Moreover, the NC of HIV-1 and HTLV-I have 
recently been shown to be zinc finger proteins capable of bind- 
ing two Zn 2+ cations for each NC molecule [21]. It was of 
interest to analyze the ability of the HIV p7 NC protein to bind 
and unwind supercoiled DNA and to elucidate its possible 
relationship to the viral topoisomerase activity. We also com- 
pared the DNA binding ability of the zinc-bound to the zinc- 
free p7 proteins. Our data show that both forms bind and 
unwind double-stranded supercoiled DNA, although the zinc- 
bound form was more efficient in binding single-stranded 
DNA. 
In addition, our results present he possibility that the un- 
winding of supercoiled DNA by this protein is the result of its 
ability to form a DNA-protein cleavable complex. 
2. Materials and methods 
2.1. H1V p7 NC 
The HIV NC protein used in this work was from a p7 stock prepared 
by Henderson L.E from the MN strain of HIV [9,21]. We examined the 
purity of this protein preparation using SDS-polyacrylamide g l (PAG) 
electrophoresis (SDS-PAGE). Increasing amounts of NC protein 
(1-10/tg) were loaded on 10% SDS-PAG or 15% SDS-PAG containing 
4 M urea. The zinc-bound and zinc-free forms were obtained as de- 
scribed by Summers et al. [21]. 
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2.2. DNA binding and DNA unwinding assay 
Increasing amounts of the zinc-bound and zinc-free p7 protein were 
added to 25/,tl DNA binding buffer containing 20 mM Tris-HCl, pH 
8.1, 1 mM dithiothreitol (DTT), 20 mM KC1 and 0.25/lg pUC-19 
supercoiled plasmid DNA. The mixture was incubated at 37°C for 30 
min. Where indicated, proteinase K was added followed by incubation 
at 50°C for 1 h. The reaction was terminated by adding 5/zl of stopping 
buffer (final concentration: 1% SDS, 15% glycerol, 0.5% Bromophenol 
blue, 50 mM EDTA, pH 8). The reaction products were analyzed by 
electrophoresis in 1% agarose using the TBE buffer (0.089 M Tris-HC1, 
0.089 M boric acid, 0.062 M EDTA) at I V/cm. The gel was stained 
with ethidium bromide (1 ,ug/ml) and photographed using a short- 
wavelength ultraviolet lamp. 
2.3. Agarose gel shift assay 
DNA labeling and purification. 32p-labeled pUC-19 fragments were 
prepared using the Random Primer DNA labeling system (BRL). To 
separate the labeled DNA from the unincorporated labeled nucleotides, 
we purified the DNA by chromatography through Sephadex G-50 
column (nick column, Pharmacia). The obtained labeled DNA was 
further purified from the enzymes used for DNA labeling by phenol/ 
chloroform extraction and was precipitated by ethanol. The labeled 
pUC-19 DNA was then dissolved in TE (10 mM Tris-HCl, pH 8, 1 mM 
EDTA ).The DNA was boiled for 10 rain, and immediately cooled prior 
to adding to the reaction mixture. 
Gel shift assay. 0.3/zg of HIV p7 protein and 10 ng (6 x 105 cpm) of 
labeled single-stranded pUC-19 fragments were added to the DNA 
binding buffer. Where indicated, increasing amount of unlabeled ou- 
ble-stranded pUC-19 DNA fragments (AatII-EcoRI) were added. 
The binding assay was performed as described above and the reaction 
products were analyzed by electrophoresis on 1% agarose gel (4 V/cm) 
in a TBE buffer. The gel was exposed to autoradiography as described 
by Sambrook et al. for unfixed wet polyacrylamide g l [22]. We found 
that it was also possible to use this method for agarose gel. The DNA 
fraction bound to the p7 was estimated by densitometric analysis of the 
autoradiogram. 
2.4. DNA protein cleavable complex assay 
HIV p7 protein (0.6 gtg) was added to the DNA binding buffer 
containing 10 ng (6 × 105 cpm) labeled single-stranded pUC-19 frag- 
ments which were purified from the free dCTP nucleotide and the 
enzymes which were used for DNA labeling as described above. Where 
indicated free [32P]dCTP was added instead of labeled DNA, or increas- 
ing amounts of cold pUC-19 DNA plasmid were added together with 
the labeled DNA. The reaction mixture was incubated for 1 h at 37°C 
and boiled for 2 min at 100°C. The PI nuclease digestion was per- 
formed as described previously [23,24]. 0.1 M (final concentration) 
sodium acetate pH 5.6 and 30 units of PI nuclease (BRL) were added 
for 2 h, at 37°C. Where indicated, 400/lg/ml of proteinase K were 
added and the reaction was further incubated for 1 h at 50°C. The 
reaction was stopped by 5 Jtl of protein sample buffer (0.5 M Tris-HCl, 
pH 6,8, 4% SDS, 0.1% Bromophenol blue, 20% glycerol, 4% V/V, 
fl-mercaptoethanol). The reaction products were boiled for 10 min and 
analyzed on 4-20% SDS-polyacrylamide gradient gel and the protein 
was transferred to nitrocellulose membrane as described [25]. Autoradi- 
ography was performed using X-ray film. The membrane was then 
further analyzed by Western blot using HIV p7 antibodies (1:2,000 
dilution) and developed by ECL Western blotting detection reagents 
(Amersham). 
2.5. V8 proteinase digestion 
The HIV p7 protein was labeled with 32p as described above using 
the PI nuclease assay. The pH of the reaction mixture was adjusted to 
pH 7.5 with 2.5/zl of 1 M Tris pH 10.5. Four units of V8 proteinase 
(Sigma) were added and the reaction was incubated for 1 h, at 37°C. 
The reaction was stopped by 5/11 of protein sample buffer and loaded 
on I0-18% gradient SDS-PAGE containing 7 M urea for separation of 
low molecular mass polypeptides. 
The proteins were then transferred to nitrocellulose membrane fol- 
lowed by autoradiography and Western blot detection using HIV p7 
antibodies. 
3. Results 
3.1. Purity of the p7 NC protein preparation 
The p7 NC protein used in this study was from the same 
batch of purified p7 preparation used in experiments reported 
elsewhere [9]. To verify the purity of this preparation, increas- 
ing amounts of this protein (1 10/zg) were analyzed on SDS- 
polyacrylamide gel electrophoresis following silver staining. 
Fig. 1A shows a major band of 7 kDa and a ladder of higher 
molecular weight bands. These additional bands represent a
ladder of multimers of 7 kDa and could be dissociated into 
7 kDa monomers by treatment with 4 M urea (Fig. 1B), it 
should be notice that this method was previously used for 
separation of histones and non-histone nuclear proteins. No 
other bands were observed, even at high protein concentra- 
tions, indicating that the p7 protein is highly purified. Interest- 
ingly, this tendency of p7 protein to form multimers at high 
concentrations resemble other nuclear non-histone protein. 
3.2. p7 NC binds and unwinds upercoiled DNA 
The DNA binding capacity of the zinc-free and zinc-bound 
p7 was examined with the plasmid pUC-19. The plasmid prep- 
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Fig. 1. Examination of the purity of the p7 NC preparation. Increasing 
amounts of the p7 protein were loaded on 10% SDS polyacrylamide g l 
(A) or on 15% SDS polyacrylamide g l containing 4 M urea (B). 1/dg 
protein (lanes 1A,4B), 5/tg protein (lanes 2A,3B), 7.5/~g protein (lanes 
3A,2B), 10/zg protein (lanes 4A, 1B). The gel was stained using the silver 
staining reagent (BRL). 
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Fig. 2. p7 binds and unwinds upercoiled DNA. Increasing amounts of 
the zinc-free form of p7 (lanes 2~5) or the zinc-bound form (lanes 7 I l ) 
were added to a DNA binding buffer and contained 0.25/lg supercoiled 
pUC-19 DNA. The reaction products were analyzed by agarose gel 
electrophoresis (a): 0.2/lg p7 (lanes 2,7), 0.3 ktg (lanes 3,8), 0.4/~g (lanes 
4,9), 0.5/~g (lanes 5 6 and 10-11). Lane 1, supercoiled pUC-19 DNA; 
lanes 6 and I l demonstrated the results obtained after proteinase K 
treatment. (b) The relative supercoiled DNA migration rate was calcu- 
lated from the results demonstrated in part (a). A, zinc-bound form; e, 
zinc-free form. Each data point represents a substraction between the 
migration distance of the control supercoiled DNA and the migration 
distance observed in the presence ofp7. 
aration used in this study contained both supercoiled and re- 
laxed molecules. 
Fig. 2a, shows that the migration of both DNA forms was 
retarded in the presence of either the zinc-bound or zinc-free 
p7, although the retardation of the supercoiled DNA was more 
prominent than that of the relaxed DNA, Both proteins im- 
posed this retardation i  a dose-dependent manner (see lanes 
2 5 for zinc-free p7 and lanes 7-10 for the zinc-bound p7). 
Proteinase K digestion of the reaction products, formed by the 
highest amount of either the zinc free (lane 6) or zinc-bound 
(lane 1 1) p7, completely abolished their retardation. It is there- 
fore evident hat this retardation resulted from the binding of 
these proteins, rather than from permanent conformational 
changes of the DNA. Interestingly, the relative amounts of the 
supercoiled DNA molecules decreased by increased oses of 
the proteins, whereas that of the unwound molecules corre- 
spondingly increased. This quantitative transition remained un- 
changed following treatment with proteinase K (lane 6 and 11, 
for the zinc-free and bound p7 respectively), indicating that the 
binding of p7 eventually eads to a complete unwinding of some 
of the supercoiled DNA molecules. Higher levels of p7 protein 
formed protein DNA complexes which did not enter into the 
agarose gek while treatment ofthese complexes with proteinase 
61 
K increased the amount of the relaxed form of the DNA (data 
not shown). It is notable that at equal concentrations of pro- 
tein, the retardation imposed by the zinc-bound p7 was greater 
than that imposed by the zinc-free p7 (Fig. 2b). This could 
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Fig. 3. Binding of p7 to single-stranded versus double-stranded pUC-19 
DNA fragments. 0 3/lg of zinc-bound (lane 2, shading) or zinc-free 
(lane 3, filled) p7 protein were added to DNA binding buffer containing 
32p-labeled single-stranded DNA fragments. The reaction products 
were analyzed on 1% agarose gel followed by autoradiography (A). The 
binding assay was also performed in the presence of increasing doses 
of unlabeled double-stranded DNA fragments and densitometric anal- 
ysis was performed on the autoradiogram and the bound single- 
stranded DNA fraction was calculated (B). Lane 1A represent 
32P-labeled single-stranded DNA. 
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either reflect differences in the DNA binding capacity of these 
two forms of the protein or result from different conformation 
of their DNA protein complexes. 
3.3. Binding of p7 to single-stranded DNA 
The binding capacity of p7 to supercoiled and relaxed dou- 
ble-stranded DNA and its unwinding activity, poses two major 
questions. (i) Since it is known that NC proteins from retro- 
viruses bind single-stranded DNA [18-20], does p7 protein bind 
single-stranded region present in the supercoiled DNA or may 
it also bind the double-stranded regions? (ii) How does p7 
protein unwind the covalently closed circular supercoiled 
DNA? 
To address the first question, we examined the binding ca- 
pacity of its zinc-free and -bound forms to 32p-labeled single- 
stranded DNA fragments derived from the pUC-19 plasmid. 
We developed an agarose gel shift assay which enabled us to 
examine the DNA binding capacity of this protein to single- 
stranded fragments of DNA. Fig. 3A demonstrates a ignificant 
DNA retardation with both of the p7 forms, suggesting that 
both forms of the protein efficiently bind single-stranded DNA 
fragments. 
3•4. Comparison of p7 affinity to double- versus ingle-stranded 
DNA 
To compare the affinity of p7 to double- versus single- 
stranded DNA, the two forms of p7 protein were incubated 
with labeled single-stranded DNA in the presence of increasing 
amounts (10 ng, 100 ng, 1,000 ng) of unlabeled ouble-stranded 
DNA fragments derived from pUC-19 plasmid (AatII EcoRI). 
The reaction products were analyzed on agarose gel electro- 
phoresis followed by autoradiography. Densitometric analysis 
on the autoradiogram was performed and the single-stranded 
DNA-bound fraction was calculated. The results demonstrated 
in Fig. 3B indicated that the zinc-bound form of the NC protein 
had a greater affinity to single-stranded DNA than to double- 
stranded DNA. Incubation of the protein in the presence of 
increasing amounts of double-stranded DNA fragments did not 
influence its potential to bind single-stranded DNA. However, 
a 
5 432 ! 54  32  ! 
b 
43-  
29-  
18- 
14-- 
4 -- 7KD 
0 
Fig. 4. p7-DNA cleavable complex formation. 0.6 pg of zinc-free (lanes 
4a,5a and 4b,5b) or zinc-bound (lanes 2a,3a and 2b,3b) of p7 protein 
were added to the DNA binding buffer containing 32p-labeled single- 
stranded DNA. P1 nuclease assay was performed and the reaction 
product was analyzed on 4-20% polyacrylamide gradient gel followed 
by Western blot analysis and autoradiography (a) or detection by p7 
antibodies (b). Lanes 3a, 5a and 3b,5b represent the results obtained 
after proteinase K treatment• The PI nuclease treatment of the 
32p-labeled DNA is shown in lane 1. 
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Fig. 5. Inhibition of 32p transfer from labeled DNA to HIV-NC protein 
by unlabeled pUC-19 DNA. 0.6 mg of zinc-bound p7 protein was added 
to the DNA binding buffer containing 32p labeled single-stranded DNA 
(lanes IA,IB) or dCTP (32p) nucleotides (lanes 5A,5B). Increasing 
amounts of unlabeled pUC-19 DNA were added to the reaction: 10 ng 
(lanes 2A,2B), 100 ng (lanes 3A,3B), 1,000 ng (lanes 4A,4B). P1 nucle- 
ase assay was performed and the reaction products were analyzed on 
10% polyacrylamide gel, transfered to nitrocellulose membrane fol- 
lowed by autoradiography (A) or detection by p7 antibodies (B). 
increasing amounts of double-stranded DNA fragments abro- 
gated the potential of the zinc-free form of p7 to bind single- 
stranded DNA fragments (i.e. 40% of the labeled single- 
stranded DNA were bound by the protein in the presence of 
1 pg of double-stranded DNA). The zinc-bound form of p7 
specifically bound single-stranded DNA whereas double- 
stranded DNA even a concentration of 100-fold, did not pre- 
vent the binding of this protein. On the other hand, the zinc-free 
form of p7 bound the two DNA structures. These data suggest 
that the two forms of the p7 differ in their DNA binding 
characteristics. 
3.5. Formation oJp7 protein-DNA cleavable complex 
The HIV p7 protein, as other retroviral NC proteins contains 
regions which are positively charged and contribute to electro- 
static interactions between p7 protein and the negatively 
charged phosphate backbone of the DNA. However, these lec- 
trostatic interactions cannot account for the p7 unwinding ac- 
tivity because to unwind a closed circular supercoiled DNA 
plasmid in an irreversible manner, a single-stranded DNA 
break in the phosphodiester backbone of the DNA should be 
formed. It has been proven that for DNA relaxing enzymes, 
such as DNA topoisomerases, the relaxation activity involves 
a formation of an enzyme-DNA cleavable complex as an inter- 
mediate product, in which a covalent bond is formed between 
the active site of the enzyme and the phosphate moiety from 
the DNA backbone [23,26,27]. Thus, topoisomerases unwind• 
supercoiled DNA by their nicking closing activity [26-27]. 
Therefore, we investigated whether p7 protein unwinds super- 
coiled DNA by the same mechanism and therefore we used the 
protein-DNA cleavable complex assay. If such a complex of 
protein-DNA is formed by covalent bonds between the protein 
and the phosphate residues of the DNA,  these residues hould 
remain bound to the protein after P1 nuclease digestion. Thus, 
the 32p-labeled single-stranded DNA fragments were interacted 
with either of the two p7 forms, followed by digestion with P1 
nuclease. After boiling in the presence of SDS, the reaction 
products were subjected to SDS polyacrylamide g l electropho- 
resis and then transferred to a nitrocellulose filter by Western 
blotting. The blot was first exposed to X-ray film for auto- 
radiography and then analyzed with p7 specific antibodies and 
the ECL detection reagent. As can be seen in Fig. 4a,b, a 7 kDa 
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Fig. 6. V8 proteinase digestion of 32p-labeled p7 obtained by P1 nuclease assay. The labeled p7 (lane 2) was treated with 4 units of V8 proteinase 
(lane 3) and the reaction products were analyzed on 10-18% polyacrylamide gradient gel containing 7 M urea. The proteins were transferred to 
nitrocellulose and autoradiography was performed (a) and the presence of the protein was also detected using HIV p7 antibodies (b). 
band was detected in both procedures (lanes 2 and 4), suggest- 
ing that the phosphate residues did indeed remain linked to the 
p7 protein. This was further substantiated by the finding that 
this band was eliminated by treating the PI digestion product 
with proteinase K prior to being loaded onto the gel (Fig. 4a,b, 
lanes 3 and 5). No significant differences were detected between 
the two p7 forms in this analysis. These results suggest that the 
p7 protein was labeled by transfer of 32p from the DNA to the 
protein. It is possible that the p7 was labeled by free labeled 
dCTP which might have remained with the DNA preparation 
after its purification. Therefore, a control assay was performed 
in which the template DNA was omitted from the random 
primer reaction. The reaction mixture was purified through a 
Sephadex G-50 column (nick column) and an equivalent vol- 
ume to that used with the labeled DNA reaction was added to 
the reaction mixture containing both forms of p7 protein. The 
results depicted in Fig. 5 are for the zinc-bound p7, similar 
results were obtained for the free zinc p7 (data not shown). Fig. 
5 lanes 5A and 5B, show that the p7 protein was not labeled 
by free dCTP. The labeling of p7 was observed only in the 
presence of labeled DNA (lanes 1A,1B). Moreover, increasing 
doses of unlabeled pUC-19 supercoiled plasmid added together 
with 32p-labeled DNA completely prevented the 32p labeling of 
the p7 protein (Fig. 5A,B, lanes 24).  These results strongly 
indicated that the radio-labeling of p7 protein was due to the 
32p transfer from the labeled DNA. Since boiling of the reaction 
products twice (once prior to the P1 digestion and once in the 
presence of SDS) did not affect the labeling of p7, it could be 
assumed that a very stable bond (probably a covalent bond) 
was formed between the labeled phosphate moiety in the DNA 
backbone and the p7 protein. 
To determine whether p7 binds the DNA through one or 
more bonds, the P1 nuclease digested product was treated with 
V8 proteinase which cleaves p7 to several peptides. Fig. 6a 
shows two 32p labeled peptides, one of 3.3 kDa and the second 
of 2 kDa (lane 3). This may suggest that phosphate residues of 
the DNA were bound to at least two sites in the p7 protein. We 
cannot rule out the possibility that these two bands reflected 
incomplete digestion of the p7 protein by V8 protease or that 
additional labeled peptides in the V8 digest existed that could 
not be detected because of their minute size. The p7 antibodies 
recognized the labeled p7 protein (Fig. 6b, lane 2), but not the 
p7 fragments (Fig. 6b, lane 3). 
4. Discussion 
The ability of retroviral NC protein to bind nucleic acids has 
been previously demonstrated for several retroviruses [18-20]. 
It has recently been shown that HIV p7 NC binds tightly to 
DNA fragments, including supercoiled plasmid containing pro- 
viral DNA sequences, and forms a high molecular weight 
DNA protein complexes [28]. Since HIV p7 NC contains two 
zinc finger binding domains [16,21] we examined the DNA 
binding properties and characteristics of the zinc-bound and 
zinc-free forms of the HIV NC. Our data demonstrate hat both 
forms (in addition to their ability to bind single-stranded DNA) 
are capable of binding double-stranded supercoiled DNA plas- 
mid and the zinc-bound form was more effective in this respect. 
Our data also suggest hat the affinity of the zinc form to 
single-stranded DNA fragments i significantly higher than for 
double-stranded DNA fragments, while that of the zinc-free 
form binds both DNAs. These data may suggest hat zinc 
influences the DNA binding properties of the NC. In addition, 
we found that when incubated with 32p-labeled single-stranded 
DNA followed by P1 nuclease digestion, the p7 protein was 
labeled. We demonstrated that the labeling of p7 can be ob- 
served only with labeled DNA and not by free labeled nucleo- 
tide. Moreover, we found that the labeling of p7 protein signif- 
icantly decreased, when unlabeled DNA was present in the 
reaction mixture. These data strongly indicate that the p7 pro- 
tein is labeled by transfer of the 32p from the DNA backbone 
to the protein. Since the labeling of the p7 protein by this 
procedure was stable in the presence of SDS and boiling, it is 
clear that the interaction between the phosphate moiety from 
the DNA and the protein is not due to electrostatic charge or 
hydrophobic interaction. Thus, we may assume that the p7 
protein forms a covalent bond with the phosphate moiety of the 
DNA backbone. Indeed it was shown that using the same P1 
nuclease method DNA topoisomerase I protein is labeled and 
this labeling is a consequence of a covalent bond formed be- 
tween the enzyme and the phosphate moiety of the DNA back- 
bone [23,24,29]. It has been previously shown that NC proteins 
are capable of unwinding a folded RNA structure by binding 
selectively to single-stranded RNA [21]. We demonstrated that 
the HIV NC protein unwinds supercoiled DNA plasmid. Since 
NC protein binds single-stranded DNA more efficiently than 
double-stranded DNA, we suggest that the HIV p7 binds sin- 
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gle-stranded regions present in the supercoiled double-stranded 
DNA. We showed that the products of the unwinding activity 
are permanently fully relaxed DNA plasmid molecules. In 
order to obtain this DNA form from a covalently closed circu- 
lar supercoiled DNA, a nick had to be formed in the phospho- 
diester bond of the supercoiled DNA. It is possible that this 
nick is formed by the p7 protein due to its ability to bind, 
presumably, covalently, the phosphate moiety of the DNA 
backbone. This bond formation is preceded by cleavage of the 
DNA strand and will lead to the relaxation of the supercoiled 
DNA. 
This relaxation mechanism resembles the first step of DNA 
topoisomerase I activity and is consistent with our previously 
reported results of the association of the HIV topoisomerase 
I activity and the viral NC protein [7]. However the purified p7 
protein did not form the typical ladders of partially relaxed 
molecules which characterized the topo I activity. It is interest- 
ing to mention that we found that V8 digestion of the 32p_ 
labeled p7 protein (which was labeled through 32p transfer from 
DNA to the protein) yielded two 32p-labeled fragments, (3 kDa 
and 2.3 kDa). This observation suggest hat at least one, and 
possibly two, bonds were formed between the p7 and the DNA. 
In accordance with the published sequence of the p7 [9], diges- 
tion of V8 proteinase produces 2.8 kDa, 2.84 kDa, 1.2 kDa and 
0.5 kDa fragments. The 2.8 kDa and the 2.84 kDa, each contain 
one zinc finger domain. Since we found that two labeled frag- 
ments were observed after the V8 proteinase digestion and their 
size, according to our electrophoresis gel conditions, were 
3 kDa and 2.3 kDa, we may assume that the two zinc finger 
domains of the p7 are involved in the bond formation between 
the phosphate moiety in the DNA backbone and the p7 protein. 
This is a possible explanation since it was shown that zinc 
coordination i E. coli DNA topoisomerase I is required for the 
transition of the noncovalent complex with DNA to the cleav- 
able state [29]. 
The ability of p7 protein to unwind supercoiled DNA sug- 
gests an additional physiological role for this protein. It is 
possible that it is involved in the integration process of proviral 
DNA into the cellular genome influences the topological state 
of the viral or cellular DNA and thus facilitates the recombina- 
tional process between the two DNAs. Moreover, during the 
reverse transcriptional process of the viral RNA, especially 
during the synthesis of the second proviral DNA strand, topol- 
ogically restricted structures may be formed. These structures 
should be removed in order to permit efficient DNA synthesis. 
Thus, p7 NC unwinding activity may be involved in this proc- 
ess, and indeed, it has been postulated that the NC protein play 
a role in assisting the replication process carried out by the 
reverse transcriptase [30]. 
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